3Deitcher SR, FesenMR, Kiproff PM, et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheterst results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol,2002, 20: 317-324.
4Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr, 2001, 139: 593-596.
5Svoboda P, Barton RP, Barbarash OL, et al. Recombinant urokinase is ssfe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Csre Med, 2004, 32:1990-1996.
6Horne MK 3rd, Thrombolytics for occluded catheters, Crit Care Med,2004, 32: 2146-2147.
7Hurtubise MR, Bottino JC, Lawson M, et al. Restoring patency of occluded central venous catheters, Arch Surg, 1980, 115:212-213.
8Lucarelli G,Galimberti M,Polehi P,Anqelucci E,Baronciani D,Giardini C,et al.Bone marrow transplantation in patients with thalassemia[J].New Engl J Med,1990,322(7):417-421.
10Imran H,Tlejeh IM,Zirakzadeh A,Rodriguez V,Khan SP.Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation:a systematic review and meta analysis[J].Bone Marrow Transplant,2006,37 (7):677-686.
